Skip to main content
Evome Medical Technologies Inc. logo

Evome Medical Technologies Inc. — Investor Relations & Filings

Ticker · EVMT ISIN · CA30053H1055 TSXV Manufacturing
Filings indexed 403 across all filing types
Latest filing 2024-02-08 Capital/Financing Update
Country CA Canada
Listing TSXV EVMT

About Evome Medical Technologies Inc.

https://www.evomemedical.com

Evome Medical Technologies Inc. is a medical device enterprise dedicated to the design, development, production, and distribution of specialized medical devices. The company's core business centers on human performance and rehabilitative solutions, specifically addressing the post-operative and recovery market. Evome aims to enhance patient outcomes through its portfolio of devices utilized in rehabilitation settings.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a non-binding letter of intent to extend acquisition debt and changes in sales targets and product pricing. It discusses financial arrangements, management comments, and forward-looking statements but does not contain actual financial statements, detailed financial performance data, or comprehensive financial analysis. It is not a full financial report like an Annual Report (10-K) or Interim Report (IR). It also does not fit categories like Earnings Release (ER) since it lacks key financial highlights or results. The document is primarily an update on financing terms and business strategy, which aligns best with Capital/Financing Update (CAP). The length (6748 characters) and content support this classification with high confidence.
2024-02-08 English
News release - English.pdf
Regulatory Filings
2024-01-31 English
Other.pdf
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce significant events. The content includes the resignation of a director, a corporate name change with amended Articles of Incorporation, and an investor presentation. The document does not contain full financial statements or detailed financial analysis typical of Annual Reports (10-K) or Interim Reports (IR). It also includes exhibits such as the Notice of Alteration and Articles reflecting the name change, which are corporate governance documents but not governance practice reports. The primary focus is on management changes and corporate structural updates. Therefore, the most appropriate classification is Board/Management Information (MANG), as it reports changes in the board and corporate structure. Confidence is high given the clear presence of director resignation and amendments to articles of incorporation.
2024-01-24 English
Certificate and Articles of Amendment.pdf
Regulatory Filings
2024-01-22 English
Certificate and articles of change of name.pdf
Regulatory Filings
2024-01-22 English
News release - English.pdf
Capital/Financing Update Classification · 90% confidence The document is a press release announcing a corporate name change, board restructuring, and strategic updates including revenue growth and product launches. It contains some financial performance highlights such as Adjusted EBITDA and revenue growth for specific quarters but does not present comprehensive financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). The document is not a full earnings release (ER) as it provides more narrative and strategic context rather than just key financial highlights. It also does not fit into categories like Board/Management Information (MANG) because it includes broader operational updates beyond just management changes. The document is a corporate announcement with financial performance commentary and forward-looking statements, typical of a Capital/Financing Update (CAP) or a general corporate update. Given the focus on restructuring, name change, and financial performance updates, the best fit is Capital/Financing Update (CAP). The document length (over 11,000 characters) and content indicate it is not a brief announcement or a simple regulatory filing. Confidence is high due to clear financial and strategic update content without full financial statements.
2024-01-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.